T44.7 Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists

Name of the Condition

• Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists
• This code covers conditions resulting from exposure to beta-adrenoreceptor antagonists (beta-blockers), including toxic effects, adverse reactions, or insufficient dosing.

Summary

This category includes poisoning, adverse effects, or underdosing related to beta-adrenoreceptor antagonists, which are medications used to manage cardiovascular conditions like hypertension, angina, and arrhythmias. The code addresses scenarios where these drugs cause harm or fail to achieve therapeutic effects.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose, incorrect administration, or interactions with other substances. Underdosing occurs when a patient receives insufficient medication to achieve the intended therapeutic effect, potentially due to dosing errors or non-adherence.

Risk Factors

• Concurrent use of multiple medications affecting cardiovascular function.
• Pre-existing conditions that alter drug metabolism or sensitivity (e.g., asthma, diabetes).
• Age-related changes in drug response (e.g., elderly or pediatric patients).
• History of substance use or misuse.

Symptoms

• Bradycardia (slow heart rate) or tachycardia (rapid heart rate).
• Fatigue, dizziness, or syncope.
• Cold extremities or Raynaud’s phenomenon.
• Difficulty breathing or wheezing.
• Hypotension or hypertension.
• Mood changes or depression.

Diagnosis

Assessment of symptoms following beta-blocker exposure. Review of patient’s medical history for known allergies or existing conditions. Monitoring vital signs and performing an EKG if needed. Toxicology screening for overdose or underdosing confirmation.

Treatment Options

• Discontinuation or dose adjustment of the beta-blocker.
• Supportive care for symptoms (e.g., IV fluids, oxygen).
• Antidotes (e.g., glucagon) for severe bradycardia or hypotension.
• Monitoring for complications (e.g., heart failure, respiratory distress).

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Most mild cases resolve with dose adjustment or discontinuation. Severe poisoning may require intensive care. Follow-up includes monitoring for recurrence and adjusting therapy as needed.

Complications

• Cardiac arrhythmias or heart failure.
• Respiratory distress or bronchospasm.
• Hypoglycemia (especially in diabetic patients).
• Worsening of underlying conditions (e.g., asthma, heart disease).

Lifestyle & Prevention

• Adhere to prescribed dosing and avoid self-adjusting medication.
• Inform healthcare providers of all medications, including over-the-counter drugs.
• Avoid abrupt discontinuation of beta-blockers to prevent rebound effects.
• Regularly monitor blood pressure and heart rate as advised.

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe dizziness, chest pain, difficulty breathing, or loss of consciousness. Contact a provider for persistent mild symptoms or concerns about dosing.

Tips for Medical Coders

• Use this code for poisoning, adverse effects, or underdosing of beta-adrenoreceptor antagonists.
• Document the clinical context (e.g., overdose, underdosing, adverse reaction) to support code assignment.
• Differentiate from other autonomic nervous system drug codes by focusing on beta-blocker-specific exposure.
• Include details on intent (accidental, intentional) or administration errors when available.